QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
NYSE:FNA

Paragon 28 - FNA Stock Forecast, Price & News

$16.85
+0.36 (+2.18%)
(As of 01/31/2023 12:00 AM ET)
Add
Compare
Today's Range
$16.43
$16.97
50-Day Range
$16.49
$21.11
52-Week Range
$12.35
$21.49
Volume
459,123 shs
Average Volume
391,669 shs
Market Capitalization
$1.31 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$27.29

Paragon 28 MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
61.9% Upside
$27.29 Price Target
Short Interest
Bearish
4.06% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.45mentions of Paragon 28 in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$5.10 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.46) to ($0.29) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.99 out of 5 stars

Medical Sector

682nd out of 1,055 stocks

Surgical & Medical Instruments Industry

68th out of 106 stocks


FNA stock logo

About Paragon 28 (NYSE:FNA) Stock

Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; and APEX 3D total ankle replacement systems; total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides bunion or hallux valgus correction systems, including nail systems phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.

Receive FNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Paragon 28 and its competitors with MarketBeat's FREE daily newsletter.

FNA Stock News Headlines

Paragon 28 prices ~$64M public offering
Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
Paragon 28, Inc. (NYSE:FNA) Short Interest Down 14.4% in December
Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
Paragon 28 Insider Trades Send a Signal
Massive Insider Trade At Paragon 28
Paragon 28, Inc. (FNA) Q3 2022 Earnings Call Transcript
Paragon 28 (FNA) Receives a Buy from Needham
Steris (STE) Q2 Earnings and Revenues Miss Estimates
Preview: Paragon 28's Earnings
FNA Paragon 28, Inc.
Paragon 28 10% Owner Trades Company's Stock
See More Headlines
Receive FNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Paragon 28 and its competitors with MarketBeat's FREE daily newsletter.

FNA Company Calendar

Last Earnings
11/10/2022
Today
1/31/2023
Next Earnings (Estimated)
3/14/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
343
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$27.29
High Stock Price Forecast
$32.00
Low Stock Price Forecast
$23.00
Forecasted Upside/Downside
+61.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
6 Analysts

Profitability

Net Income
$-13,690,000.00
Pretax Margin
-19.78%

Debt

Sales & Book Value

Annual Sales
$147.46 million
Book Value
$2.52 per share

Miscellaneous

Free Float
62,606,000
Market Cap
$1.31 billion
Optionable
Not Optionable
Beta
0.81

Key Executives

  • Mr. Albert  DaCostaMr. Albert DaCosta (Age 48)
    Co-Founder, Chairman & CEO
    Comp: $886.09k
  • Mr. Stephen M. DeitschMr. Stephen M. Deitsch (Age 51)
    CFO & Principal Fin. Officer
    Comp: $599.6k
  • Mr. Matthew Jarboe (Age 38)
    Chief Commercial Officer
    Comp: $801.44k
  • Mr. Jeff Sears
    VP of Operations
  • Mr. Erik Mickelson
    Chief Accounting Officer & Controller
  • Jason Edie
    Chief Technology Officer
  • Matt Brinckman
    Sr. VP of Strategy & Investor Relations
  • Ms. Michelle Missal
    VP & Chief Compliance Officer
  • Mr. Jonathan Friedman (Age 51)
    Gen. Counsel & Sec.
  • Mr. John Shumaker
    Exec. VP of Sales - U.S.













FNA Stock - Frequently Asked Questions

Should I buy or sell Paragon 28 stock right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Paragon 28 in the last twelve months. There are currently 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" FNA shares.
View FNA analyst ratings
or view top-rated stocks.

What is Paragon 28's stock price forecast for 2023?

6 Wall Street analysts have issued 1 year price targets for Paragon 28's stock. Their FNA share price forecasts range from $23.00 to $32.00. On average, they expect the company's stock price to reach $27.29 in the next twelve months. This suggests a possible upside of 63.1% from the stock's current price.
View analysts price targets for FNA
or view top-rated stocks among Wall Street analysts.

How have FNA shares performed in 2023?

Paragon 28's stock was trading at $19.11 at the beginning of 2023. Since then, FNA shares have decreased by 12.5% and is now trading at $16.73.
View the best growth stocks for 2023 here
.

Are investors shorting Paragon 28?

Paragon 28 saw a drop in short interest during the month of December. As of December 30th, there was short interest totaling 1,010,000 shares, a drop of 14.4% from the December 15th total of 1,180,000 shares. Based on an average daily trading volume, of 197,200 shares, the days-to-cover ratio is presently 5.1 days. Currently, 3.9% of the company's stock are short sold.
View Paragon 28's Short Interest
.

When is Paragon 28's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 14th 2023.
View our FNA earnings forecast
.

How were Paragon 28's earnings last quarter?

Paragon 28, Inc. (NYSE:FNA) released its quarterly earnings results on Thursday, November, 10th. The company reported ($0.13) EPS for the quarter, hitting analysts' consensus estimates of ($0.13). The business earned $46.01 million during the quarter, compared to analyst estimates of $42.48 million. Paragon 28 had a negative trailing twelve-month return on equity of 19.17% and a negative net margin of 20.12%.

What guidance has Paragon 28 issued on next quarter's earnings?

Paragon 28 updated its fourth quarter 2022 earnings guidance on Sunday, January, 29th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $51.20 million-$51.50 million, compared to the consensus revenue estimate of $49.56 million.

When did Paragon 28 IPO?

(FNA) raised $125 million in an initial public offering on Friday, October 15th 2021. The company issued 7,800,000 shares at a price of $15.00-$17.00 per share. BofA Securities and Piper Sandler acted as the underwriters for the IPO and Canaccord Genuity, JMP Securities and Needham & Company were co-managers.

What is Paragon 28's stock symbol?

Paragon 28 trades on the New York Stock Exchange (NYSE) under the ticker symbol "FNA."

Who are Paragon 28's major shareholders?

Paragon 28's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Calamos Advisors LLC (0.12%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Albert Dacosta, Frank S Bono, Lee Rosenthal, Matthew Jarboe and Mvm Partners Llp.
View institutional ownership trends
.

How do I buy shares of Paragon 28?

Shares of FNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Paragon 28's stock price today?

One share of FNA stock can currently be purchased for approximately $16.73.

How much money does Paragon 28 make?

Paragon 28 (NYSE:FNA) has a market capitalization of $1.30 billion and generates $147.46 million in revenue each year. The company earns $-13,690,000.00 in net income (profit) each year or ($0.45) on an earnings per share basis.

How many employees does Paragon 28 have?

The company employs 343 workers across the globe.

How can I contact Paragon 28?

The official website for the company is www.paragon28.com. The company can be reached via phone at 720-912-1332 or via email at ir@paragon28.com.

This page (NYSE:FNA) was last updated on 1/31/2023 by MarketBeat.com Staff